HC Wainwright & Co. maintains Buy rating on Mirum Pharmaceuticals, $195 price target
HC Wainwright & Co. maintained their Buy rating on Mirum Pharmaceuticals's stock with a price target of $195.00.The price target implies an upside of 117.4% from the Sep 25 close of $89.70.Key takeaways from the analyst noteStrong Pipeline and Positive Clinical Data: Mirum Pharmaceuticals has demon…